ICD-11 revision launch
An alpha draft of ICD-11 was released to the public for review in July 2011. This was the first step in allowing wider participation of the global health community and multiple stakeholders in the development process of ICD-11.
In July 2011, the AIHW (as the ACC) hosted an Australian event to announce the ICD-11 revision process. This event, titled Think before you measure, was held in association with a symposium on classifications and hosted by the University of Sydney. The event announced the ICD-11 revision and the opportunity for public review to promote participation in the process.
ICD-11 field testing
In 2016-17, as part of the then ICD-11 Revision project plan, the AIHW lead the first phase of morbidity field testing of ICD-11 MMS in Australia, on behalf of WHO. The goals of this field testing were to:
- inform whether ICD-11 was fit for purpose
- identify any changes and enhancements that may be required, and
- confirm any transitional and implementation issues.
The Australian Bureau of Statistics conducted ICD-11 MMS field testing for mortality purposes at the same time. Results from both tests showed more work was required.
Phase 2 morbidity field testing followed in 2017, with Phase 3 undertaken in 2018. These tests assessed the ease of use of the post-coordination functions of the classification and more complex scenarios for coding.
As part of socialising the classification in Australia, three workshops have been held in 2017, 2018 and in 2021 to update stakeholders on the progress of ICD-11 development by WHO and ascertain issues and considerations for its potential implementation in Australia.
The AIHW commissioned Shepheard Management Consultants to undertake in depth consultations with stakeholders during late 2018 and early 2019, resulting in a number of recommendations to assist the ICD-11 decision making process in Australia. The ICD-11 Review stakeholder consultation report was published in 2020.
The third stakeholder workshop in 2021 was held to validate the recommendations made in this report.
If you would like further information on ICD-11 please contact the ACC at [email protected].